March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Diffuse versus Non-diffuse Choroidal Melanoma: Comparative study
Author Affiliations & Notes
  • Swathi Kaliki
    Ocular Oncology, Wills Eye Institute, Philadelphia, Pennsylvania
  • Carol L. Shields
    Ocular Oncology, Wills Eye Institute, Philadelphia, Pennsylvania
  • Minoru Furuta
    Ocular Oncology, Wills Eye Institute, Philadelphia, Pennsylvania
  • Jerry A. Shields
    Ocular Oncology, Wills Eye Institute, Philadelphia, Pennsylvania
  • Footnotes
    Commercial Relationships  Swathi Kaliki, None; Carol L. Shields, None; Minoru Furuta, None; Jerry A. Shields, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 3388. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Swathi Kaliki, Carol L. Shields, Minoru Furuta, Jerry A. Shields; Diffuse versus Non-diffuse Choroidal Melanoma: Comparative study. Invest. Ophthalmol. Vis. Sci. 2012;53(14):3388.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To determine and compare the prognosis of small choroidal melanoma (< 3 millimeters thickness) comparing diffuse versus (vs) non-diffuse configuration.

Methods: : Diffuse choroidal melanoma (flat configuration) was compared with non-diffuse small choroidal melanoma (dome-shaped configuration) retrospectively.

Results: : In the diffuse melanoma group (n=297), 29 (10%) patients developed metastasis and 21 (7%) melanoma-related death over mean follow-up period of 76 months. In the non-diffuse melanoma group (n=1454), 89 (6%) patients developed metastasis and 34 (2%) melanoma-related death occurred over mean follow-up period of 75 months. Using Kaplan-Meier survival estimates, the probability of developing metastasis in patients with diffuse vs non-diffuse choroidal melanoma was 5% vs 2% at 3 years, 8% vs 4% at 5 years, 17% vs 10% at 10 years (p=0.0344). The probability of melanoma-related death was 3% vs <1% at 3 years, 6% vs 2% at 5 years, 11% vs 4% at 10 years (p<0.0001). By multivariate analysis, factors predictive of metastasis included larger tumor basal dimension (p=0.0027) and plateau tumor configuration (p=0.0257) for diffuse melanoma vs extraocular extension (p=0.0207) for non-diffuse choroidal melanoma. Factors predictive of death included extraocular extension (p=0.0016) and plateau tumor configuration (p=0.0002) for diffuse melanoma vs amelanotic melanoma (p=0.0157) for non-diffuse choroidal melanoma.

Conclusions: : Patients with small choroidal melanoma show statistically higher probability of metastasis and death if tumor configuration is diffuse compared to non-diffuse.

Keywords: choroid • tumors • uvea 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×